Jiangsu Hengrui Pharmaceuticals Co. Ltd. (JHPCY)
OTC
20.00
0.00 (0.00%)
Closed
Aug 21, 2026
Day's Range
20.0020.00
52 wk Range
13.6020.00
Financial Statements - JHPCY - Jiangsu Hengrui Pharmaceuticals Co. Ltd.
Revenue
31.62B▲ 672.4%
Net Income
7.71B▲ 732.3%Net Margin 24.4%
EBITDA
9.49B▲ 728.0%
Free Cash Flow
8.27B▲ 936.8%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Sales | 31.62B | 4.09B |
| Cost of Goods | 4.36B | 563.06M |
| Gross Profit | 27.26B | 3.53B |
 Operating Expense | - | - |
| Operating Income | 8.59B | 995.43M |
| Non-Operating Interest | - | - |
| Other Income Expense | - | - |
| Pre Tax Income | 8.70B | 1.04B |
| Income Tax | 990.62M | 121.83M |
| Net Income | 7.71B | 927.22M |
| EPS Basic | 2.38 | 1 |
| EPS Diluted | 2.36 | 1 |
| Basic Shares Outstanding | 3.23B | 927.16M |
| Diluted Shares Outstanding | 3.23B | 927.16M |
| Ebit | 8.72B | 1.04B |
| Ebitda | 9.49B | 1.14B |
| Net Income Continuous Operations | 7.71B | 927.22M |
| Minority Interests | -5.94M | -467.63K |
| Preferred Stock Dividends | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
